Press Releases on September 25, 2023 - EIN Presswire - Press Release Distribution Service

Published on September 25, 2023 - 20:05 GMT

QIAGEN erweitert QIAwave-Portfolio um neue, umweltfreundlichere Nukleinsäure-Extraktionskits

VENLO, Niederlande, Sept. 25, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) hat heute die Erweiterung seiner umweltfreundlicheren QIAwave-Produktlinie um zwei neue Nukleinsäure-Extraktionskits bekannt gegeben: Bei dem QIAwave …

Distribution channels: Media, Advertising & PR, Technology ...

Published on September 25, 2023 - 20:05 GMT

Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost

TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased …

Distribution channels:

Published on September 25, 2023 - 20:05 GMT

Pliant Therapeutics to Host Investor Call and Webcast to Discuss Interim Results from INTEGRIS-PSC, a Phase 2a Trial in Patients ...

SOUTH SAN FRANCISCO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced it will host a conference call and webcast on Tuesday, September 26, 2023 at 8:00 a.m. ET | 5:00 a.m. PT to discuss the interim results …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on September 25, 2023 - 20:05 GMT

nCino to Host Inaugural Investor Day

WILMINGTON, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ:NCNO), a pioneer in cloud banking for the global financial services industry, will host an Investor Day at its headquarters in Wilmington, NC on September 28, 2023 from 9:00am until …

Distribution channels: Culture, Society & Lifestyle, Technology ...

Published on September 25, 2023 - 20:05 GMT

Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023

BETHESDA, Md., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (the “Company”), a biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that the …

Distribution channels:

Published on September 25, 2023 - 20:01 GMT

Celyad Oncology announces the termination of its American Depository Receipt program

MONT-SAINT-GUIBERT, Belgium, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announces that Citibank, N.A., as depositary (“Citibank”), shall issue the notice of terminating its American …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on September 25, 2023 - 20:01 GMT

Locanabio Announces Participation in Chardan’s 7th Annual Genetic Medicines Conference

SAN DIEGO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Locanabio, Inc., a genetic medicines company developing RNA-targeted therapeutics for patients with rare genetic neuromuscular and neurodegenerative diseases, today announced that Jim Burns, Ph.D., Locanabio’s …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...